These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16107202)

  • 1. Coxsackievirus-induced myocarditis: new trends in treatment.
    Liu Z; Yuan J; Yanagawa B; Qiu D; McManus BM; Yang D
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):641-50. PubMed ID: 16107202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Products as a Paradigm for the Treatment of Coxsackievirus - induced Myocarditis.
    Khanna M; Gautam A; Rajput R; Sharma L
    Curr Top Med Chem; 2020; 20(8):607-616. PubMed ID: 31995007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury.
    Esfandiarei M; Suarez A; Amaral A; Si X; Rahmani M; Dedhar S; McManus BM
    Circ Res; 2006 Aug; 99(4):354-61. PubMed ID: 16840719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease.
    Ilbäck NG; Wesslén L; Pauksen K; Stålhandske T; Friman G; Fohlman J
    Scand J Infect Dis Suppl; 1993; 88():117-23. PubMed ID: 8390714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
    Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
    Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.
    Fechner H; Pinkert S; Geisler A; Poller W; Kurreck J
    Molecules; 2011 Oct; 16(10):8475-503. PubMed ID: 21989310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations.
    Pauksen K; Ilbäck NG; Friman G; Fohlman J
    Scand J Infect Dis Suppl; 1993; 88():125-30. PubMed ID: 8390715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral treatment with WIN 54 954 reduces mortality in murine coxsackievirus B3 myocarditis.
    Fohlman J; Pauksen K; Hyypiä T; Eggertsen G; Ehrnst A; Ilbäck NG; Friman G
    Circulation; 1996 Nov; 94(9):2254-9. PubMed ID: 8901680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of viral heart disease.
    Kandolf R
    Herz; 1993 Aug; 18(4):238-44. PubMed ID: 8397158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocarditis and cardiomyopathy].
    Kandolf R
    Verh Dtsch Ges Pathol; 1996; 80():127-38. PubMed ID: 9064995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enteroviral myocarditis and dilated cardiomyopathy].
    Kandolf R
    Med Klin (Munich); 1998 Apr; 93(4):215-22. PubMed ID: 9594530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of viral myocarditis caused by coxsackievirus B.
    Brunetti L; DeSantis ER
    Am J Health Syst Pharm; 2008 Jan; 65(2):132-7. PubMed ID: 18192257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
    Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral causes of human myocarditis.
    Andréoletti L; Lévêque N; Boulagnon C; Brasselet C; Fornes P
    Arch Cardiovasc Dis; 2009; 102(6-7):559-68. PubMed ID: 19664576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
    Shi Y; Chen C; Lisewski U; Wrackmeyer U; Radke M; Westermann D; Sauter M; Tschöpe C; Poller W; Klingel K; Gotthardt M
    J Am Coll Cardiol; 2009 Apr; 53(14):1219-26. PubMed ID: 19341864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
    Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
    Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Minor Bupleurum decoction in the treatment of viral myocarditis models].
    Wang X; Zhang G; Liang Y; Chen C; Qiu S
    Zhongguo Zhong Yao Za Zhi; 1997 Nov; 22(11):684-6, 704. PubMed ID: 11243188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.